clodronic acid has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbassi, R; Blank, A; Gress, TM; Griesmann, H; Haybaeck, J; Hüttelmaier, S; Krug, S; Michl, P; Perren, A; Rexin, P; Rinke, A; Sipos, B; Wiese, D | 1 |
| Drexel, C; Gress, TM; Griesmann, H; Michl, P; Milosevic, N; Rosendahl, J; Sipos, B | 1 |
| Fritze, D; Harjung, H | 1 |
3 other study(ies) available for clodronic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Disease Models, Animal; Drug Carriers; Drug Synergism; Female; Humans; Insulinoma; Liposomes; Macrophages; Male; Mice; Mice, Transgenic; Middle Aged; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Sunitinib; Young Adult | 2018 |
Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
Topics: Animals; Antineoplastic Agents; CD11b Antigen; CD4-Positive T-Lymphocytes; Cell Proliferation; Clodronic Acid; Interleukin-2 Receptor alpha Subunit; Liposomes; Liver Neoplasms; Lung Neoplasms; Macrophages; Mice; Models, Genetic; Neoplasms, Experimental; Neovascularization, Pathologic; Pancreatic Neoplasms; T-Lymphocytes; Tumor Burden; Vascular Endothelial Growth Factor A | 2017 |
[Monotherapy with clodronate for tumor-induced hypercalcemia].
Topics: Aged; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pancreatic Neoplasms; Plasmacytoma; Uterine Neoplasms | 1990 |